CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash flows provided by (used in) operating activities:
Net loss	$ (15,600)	$ (13,057)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	513	525
Amortization of intangible assets	12,431	14,727
Amortization of deferred contract costs	2,860	1,875
Equity-based compensation	11,128	6,872
Amortization of debt issuance costs	176	176
Provision for doubtful accounts receivable	22	9
Non-cash restructuring charges related to office leases	157	0
Tax receivable agreement remeasurement	3,619	248
Deferred income taxes	(773)	69
Changes in operating assets and liabilities:
Accounts receivable	6,966	8,526
Prepaid expenses and other current assets	(3,796)	692
Deferred contract costs	(4,021)	(3,299)
Contingent consideration	0	(6,400)
Accounts payable, accrued expenses and other liabilities	(4,294)	(3,579)
Deferred revenue	5,569	6,249
Net cash provided by operating activities	14,957	13,633
Cash flows (used in) provided by investing activities:
Purchases of property, equipment and other assets	(1,338)	(794)
Purchases of short-term investments	(90,252)	(109,559)
Maturities of short-term investments	58,120	0
Cash paid for acquisitions, net of cash acquired	0	(56,499)
Net cash used in investing activities	(33,470)	(166,852)
Cash flows used in financing activities:
Repayments of term loans	(1,719)	(1,719)
Taxes paid related to net share settlement of equity awards	(1,530)	0
Payment of contingent consideration	0	(1,100)
Payments under tax receivable agreement	(246)	0
Payments of equity offering issuance costs	(30)	(1,299)
Member distributions	0	(258)
Net cash used in financing activities	(3,525)	(4,376)
Net decrease in cash and cash equivalents	(22,038)	(157,595)
Effect of exchange rate changes on cash and cash equivalents	65	(108)
Cash and cash equivalents, beginning of period	146,934	387,498	$ 387,498
Cash and cash equivalents, end of period	124,961	229,795	$ 146,934
Supplemental cash flow disclosures:
Interest	3,475	1,771
Income taxes	79	0
Acquisitions:
Net assets acquired, net of cash acquired	0	97,499
Initial cash investment in prior year	0	(40,000)
Contingent consideration	0	(1,000)
Net cash paid for acquisitions	0	56,499
Supplemental disclosure of non-cash investing activities:
Capital expenditures included in accrued expenses	$ 333	$ 3,500